Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04184141
Other study ID # 2018-0195
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date December 1, 2019
Est. completion date September 1, 2020

Study information

Verified date December 2019
Source Istanbul Medeniyet University
Contact OZGUN TOPCUOGLU, MD
Phone +905318970188
Email ozgntopcuoglu@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients will be divided into three groups. Group H patients will be given 100 mg Hydroxyzine orally 1 hour before surgery while group A patients will receive 0.5 mg Alprazolam orally. group P will be placebo group. Amsterdam Preoperative Anxiety and Knowledge Scale (APAIS) anxiety scores will be evaluated and recorded 1 hour before surgery. APAIS score will be evaluated again in the the operation room before surgery started. After base measurements of patients are recorded with standard monitoring, spinal block will be performed with 15 mg Heavy Bupivacaine from the L2-L3 or L3-L4 levels of spinal cord in sting position. When T10 level sensory block and Bromage 0-1 neuromusculer block will be occured , surgery will be started. Heart rate, non-invasive arterial blood pressure and the degree of peripheral O2 saturation will be measured at 5 minutes interval throughout the operation. IOWA anesthesia satisfaction scale will also performed to the patients the day after the surgery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date September 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- sacrococcygeal dermoid cyst patients

- Saceptance of spinal anaesthesia

- between 18-60 years old patients

- ASA I-II

Exclusion Criteria:

- drug allergy

- BMI>35kg/m2

- psychiatric disorders

- serious renal and hepatic damage

- coagulation disorders

- serious cardiac and respiratory disorderders

- rejection of spinal anesthesia

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hydroxyzine Hydrochloride
Hyroxyzine hydrochloride is given to the patient one hour before surgery.
Alprazolam tablet
Alprozolam is given to the patient one hour before surgery.
Placebo
Placebo candy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medeniyet University

Outcome

Type Measure Description Time frame Safety issue
Primary preopartive anxiety Amsterdam Preoperative Anxiety and Information Scale (APAIS) (between 0-30) 1 hour later orally admition of drugs
Secondary Patient satisfaction IOWA pation satisfaction scale (between 9-54) 24 hours after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05264077 - Sedating Effects of Dexmedetomidine Versus Midazolam in Agitated Patients Undergoing Weaning in Icu. Early Phase 1
Completed NCT05451381 - Vasopressor Requirements Depends on Sedation Strategy N/A
Completed NCT04270331 - Assessment and Management of Pain, Agitation, Delirium and Sleep Deprivation (PADS) in ICU by PADS Protocol, Thailand N/A